|
|
Line 23: |
Line 23: |
| <div style="border-radius: 0 0 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #A1BCDD; text-align: center;"> | | <div style="border-radius: 0 0 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 30px; line-height: 30px; width: 225px; background: #A1BCDD; text-align: center;"> |
| <font color="#FFF"> | | <font color="#FFF"> |
| '''Gram-Negative''' | | '''Viral Conjunctivitis''' |
| </font> | | </font> |
| </div> | | </div> |
Revision as of 20:08, 3 February 2014
▸ Click on the following categories to expand treatment regimens.
Conjunctivitis Medical Therapy
▸ Bacterial Conjunctivitis
▸ Gram-Negative Cocci in Pairs
▸ Gram-Negative Coccobacilli
|
Bacterial Conjunctivitis
|
Preferred Regimen
|
Non-gonococcal
|
▸ Ciprofloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days OR ▸ Gatifloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days OR ▸ Levofloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days OR ▸ Moxifloxacin 1–2 gtts q2h while awake x 1st 2 days, then q4–8h x 7 days
|
Gonococcal
|
Adult dose
|
▸ Ciprofloxacin 1 gm IM/IV as 1 dose
|
Pediatric dose
|
▸ Ciprofloxacin 25-50 mg/kg IV/IM (not to exceed 125 mg) as 1 dose
|
Alternative Regimen (for non-gonococcal only)
|
▸ Polymyxin B + Trimethoprim 1–2 gtts q3–6h x 7–10 days OR ▸ Azithromycin 1%, 1 gtt bid x 2 days, then 1 gtt daily x 5 days
|
Chlamydia Trachomatis
|
Preferred Regimen
|
▸ Azithromycin 1 gm once or twice weekly
|
Alternative Regimen
|
▸ Doxycycline 100 mg bid po x 7 days
|
|
Newborn Conjunctivitis
|
N. gonorrhoeae (after 2-5 days)
|
▸ Ceftriaxone 25-50 mg/kg IV x 1 dose (not to exceed 125 mg)
|
C. trachomatis (after 3-10 days)
|
▸ Erythromycin base or ethyl succinate syrup 12.5 mg/kg q6h x 14 days OR ▸ Azithromycin suspension 20 mg/kg po q24h x 3 days
|
H. simplex (after 2-16 days) †
|
▸ Acyclovir 60 mg/kg/day IV divided into 3 daily doses OR ▸ Trifluridine OR Vidarabine as a topical antiviral therapy
|
† Systemic and CNS disease should be evaluated with PCR of CSF and serum and LFTs in any child with suspected HSV eye infection.
|
|
|